← SynDRA
FR-122047
SynDRA canonical compound SYN0001115 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Mechanism of action | cyclooxygenase inhibitor |
All known targets
Mechanisms of action (all sources)
- PTGS1 INHIBITOR
- cyclooxygenase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- HSD17B10
- USP1
- TSHR
- TDP1
- RGS4
- PTGS2
- KDM4E
- KAT2A
- HPGD
- ALOX15B
- HDAC6
- GLA
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Cyclooxygenase Inhibitors
Cross-references
Synonyms
- FR122047
- FR 122047 hydrochloride
- RefChem:73845
- FR122047 (hydrochloride)
- FR122047 hydrochloride
- SR-01000597794
- FR-122047 HCl
- C23H26ClN3O3S
- orb1305810
- SCHEMBL9548002
- EX-A15418
- MFCD05863931
- AKOS022180740
- TS-08284
- DB-041983
- HY-103386
- CS-0027790
- E80528
- T22790
- SR-01000597794-1
- SR-01000597794-2
- FR 122047 hydrochloride, >=98% (HPLC), powder
- RefChem:141461
- NCGC00025192-01
- Tocris-1507
- GTPL5191
- SCHEMBL9548128
- CHEBI:92538
- UBHKJRYGKOSQDJ-UHFFFAOYSA-N
- BDBM50376403
- NCGC00025192-02
- BRD-K30990140-003-01-6
- BRD-K30990140-003-02-4
- [4,5-bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone
Look up FR-122047 in the interactive SynDRA portal →